Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1999The Journal of ImmunologyOpen Access

Human Glioma-Induced Immunosuppression Involves Soluble Factor(s) That Alters Monocyte Cytokine Profile and Surface Markers

View Full Paper
Ask AI
Bookmark
Share

Authors

JZJian-Ping ZouTianjin Municipal Research Institute for Family PlanningLMLorri A. MorfordUniversity of KentuckyCCClaire ChougnetCincinnati Children's Hospital Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zou et al. (1999) studied this question.

synapsesocial.com/papers/6a787e57e29fd788c9f805b2https://doi.org/10.4049/jimmunol.162.8.4882
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.1995 · 468 citations
  2. 2IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells1997 · 604 citations
  3. 3Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.1989 · 391 citations
  4. 4Cytokine Dysregulation in Invasive Cervical Carcinoma and Other Human Neoplasias: Time to Consider the TH1/TH2 Paradigm1998 · 115 citations